Revisiting Freund's incomplete adjuvant for vaccines in the developing world

This publication has 13 references indexed in Scilit:

• Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria
  Infection and Immunity, 2005
• Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial
  The Lancet, 2004
• Biochemical and Immunological Characterization of Bacterially Expressed and RefoldedPlasmodium falciparum42-Kilodalton C-Terminal Merozoite Surface Protein 1
  Infection and Immunity, 2003
• A New MF59-Adjuvanted Influenza Vaccine Enhances the Immune Response in the Elderly with Chronic Diseases: Results from an Immunogenicity Meta-Analysis
  Gerontology, 2003
• Vaccination of Monkeys with RecombinantPlasmodium falciparumApical Membrane Antigen 1 Confers Protection against Blood-Stage Malaria
  Infection and Immunity, 2002
• Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines
  Expert Review of Vaccines, 2002
• Perspective: Hypothesis: Serum IgG Antibody Is Sufficient to Confer Protection against Infectious Diseases by Inactivating the Inoculum
  The Journal of Infectious Diseases, 1995
• LONG-TERM MORTALITY FOLLOW-UP OF ARMYRECRUITS WHO RECEIVED ADJUVANT INFLUENZA VIRUS VACCINE IN 1951–19531
  American Journal of Epidemiology, 1972
• A Cell Culture Assay to Evaluate the Toxicity of Arlacel A
  Experimental Biology and Medicine, 1970
• Influence of Antigens on Release of Free Fatty Acids from Arlacel A (Mannide Monooleate)
  Experimental Biology and Medicine, 1966